Home β€Ί Stock analysis β€Ί EVH

Evolent Health (EVH) Latest Stock Analysis Report – Oct 15, 2026, 4:00 PM ET

Updated Oct 15, 2026, 4:00 PM ET

What changed since yesterday

EVH rises 3.0% to $4.87, a 1-month high, 5 up days in a row. Closed at $4.87, +2.96% vs the prior close of $4.73. Day range $4.75–$5.11, opened at $4.75.

Last close$4.87+2.96%
Day range4.75–5.11
Open4.75
Volume3.84M
52-week range2.10–8.30
Avg volume (20d)2.18M

EVH daily analysis β€” what happened

A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.

Oct 15, 2026 β€” EVH rises 3.0% to $4.87, a 1-month high, 5 up days in a row
Oct 14, 2026 β€” EVH rises 2.8% to $4.73, a 1-month high, 4 up days in a row
Oct 13, 2026 β€” EVH jumps 8.2% to $4.60, a 1-month high, 3 up days in a row
Oct 12, 2026 β€” EVH jumps 5.2% to $4.25, a 1-month high
Oct 9, 2026 β€” EVH rises 2.0% to $4.04
Oct 8, 2026 β€” EVH slides 4.3% to $3.96
Oct 7, 2026 β€” EVH jumps 7.8% to $4.14, 4 up days in a row
Oct 6, 2026 β€” EVH jumps 6.4% to $3.84, 3 up days in a row
Oct 5, 2026 β€” EVH jumps 4.3% to $3.61
Oct 2, 2026 β€” EVH rises 2.1% to $3.46

EVH latest news & SEC filings

Every SEC filing by or about EVH in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.

Sep 8, 2026 Β· Form SCHEDULE 13G/A β€” Update to a passive 5%+ stake (13G)

Update to a passive 5%+ stake (13G)

Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.

Source: SEC EDGAR filing 0000895421-26-000280

Aug 28, 2026 Β· Form 4 β€” Insider trade

Insider trade report (Form 4) β€” a director, officer or 10%+ owner changed their holdings

Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.

Source: SEC EDGAR filing 0001628908-26-000088

Aug 26, 2026 Β· Form 144 β€” Planned insider sale

Notice of proposed sale (Form 144) β€” an insider or affiliate plans to sell restricted or control shares

A notice of intent, not a completed sale. Any actual sale by a director or officer shows up later on Form 4.

Source: SEC EDGAR filing 0001628280-26-059130

Aug 6, 2026 Β· Form 10-Q β€” Quarterly report

Quarterly report (unaudited financial statements for the quarter)

Quarter ended Jun 30, 2026:

Source: SEC EDGAR filing 0001628908-26-000086

Aug 6, 2026 Β· Form 8-K β€” Major event / current report

Current report β€” a filing companies must make within 4 business days of a major event

This is a results-day filing: the earnings press release is attached as an exhibit.

Source: SEC EDGAR filing 0001628908-26-000084

Jul 17, 2026 Β· Form SCHEDULE 13G β€” Passive stake (13G)

Passive stake (13G) β€” an investor reported owning more than 5%

Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.

Source: SEC EDGAR filing 0002052113-26-000714

Jul 6, 2026 Β· Form 4 β€” Insider trade

Insider trade report (Form 4) β€” a director, officer or 10%+ owner changed their holdings

Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).

Source: SEC EDGAR filing 0001628908-26-000070

Jul 6, 2026 Β· Form 4 β€” Insider trade

Insider trade report (Form 4) β€” a director, officer or 10%+ owner changed their holdings

Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).

Source: SEC EDGAR filing 0001642833-26-000004

Jul 6, 2026 Β· Form 4 β€” Insider trade

Insider trade report (Form 4) β€” a director, officer or 10%+ owner changed their holdings

Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).

Source: SEC EDGAR filing 0001628908-26-000068

Jul 6, 2026 Β· Form 4 β€” Insider trade

Insider trade report (Form 4) β€” a director, officer or 10%+ owner changed their holdings

Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).

Source: SEC EDGAR filing 0001628908-26-000066

Things to know before you trade EVH

EVH market data (last 20 sessions)

DateOpenHighLowCloseVolume
Oct 15, 20264.755.114.754.873.84M
Oct 14, 20264.524.764.494.732.27M
Oct 13, 20264.304.714.164.602.56M
Oct 12, 20264.044.254.044.251.18M
Oct 9, 20264.004.183.984.041.07M
Oct 8, 20264.104.123.843.962.88M
Oct 7, 20263.794.183.784.142.80M
Oct 6, 20263.663.873.633.841.59M
Oct 5, 20263.453.643.443.611.34M
Oct 2, 20263.423.583.323.461.77M
Oct 1, 20263.483.513.343.391.97M
Sep 30, 20263.533.583.413.491.70M
Sep 29, 20263.683.683.453.523.26M
Sep 28, 20263.573.713.493.653.40M
Sep 25, 20263.523.653.433.612.99M
Sep 24, 20263.623.663.513.521.89M
Sep 23, 20263.733.783.603.621.01M
Sep 22, 20263.723.813.653.801.53M
Sep 21, 20263.703.743.583.692.00M
Sep 18, 20263.653.723.623.692.56M

About Evolent Health

Evolent Health (EVH) is listed on the NYSE and classified by the SEC under β€œServices-Management Services”. Its business address is in ARLINGTON, VA. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 1628908.

EVH board of directors & executives

From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).

Directors

NameRoleLatest filing
Toyin AjayiDirectorJun 8, 2026
Craig A. BarbaroshDirectorJun 8, 2026
Seth BlackleyChief Executive OfficerJul 6, 2026
Peter J GruaDirectorJun 8, 2026
Shawn M GuertinDirectorJun 8, 2026
Russell Monroe GlassDirectorJun 8, 2026
Richard M JelinekDirectorJun 8, 2026
Kim KeckDirectorJun 8, 2026
Jill D. SmithDirectorJun 8, 2026
Brendan B SpringstubbDirectorJun 8, 2026

Executive officers

NameTitleLatest filing
Seth BlackleyChief Executive OfficerJul 6, 2026
Daniel Joseph MccarthyPRESIDENTAug 28, 2026
Mario RamosChief Financial OfficerMar 4, 2026
Aammaad ShamsChief Accounting OfficerJul 6, 2026
Jonathan WeinbergGeneral CounselJul 6, 2026

Recent insider buys & sales

DateInsiderTypeSharesPrice
Aug 26, 2026Daniel Joseph MccarthySale65,892$5.00
Nov 18, 2025Brendan B SpringstubbBuy10,000$3.82

EVH financials (annual, from XBRL filings)

Fiscal year endRevenueNet incomeDiluted EPSOperating cash flow
Dec 31, 2025$1.88B$-534.51M-5.07$38.84M
Dec 31, 2024$2.55B$-61.62M-0.81$18.77M
Dec 31, 2023$1.96B$-113.04M-1.28$142.58M
Dec 31, 2022$1.35B$-19.16M-0.20$-11.55M
Dec 31, 2021$907.96M$-37.60M-0.44$38.75M

Latest balance sheet: total assets $1.97B, total liabilities $1.59B, cash $115.70M (as of Jun 30, 2026).

EVH earnings / results-day log

DateFilingClose that day
Aug 6, 20268-K Item 2.02 (results)$3.59
May 7, 20268-K Item 2.02 (results)$4.27
Feb 24, 20268-K Item 2.02 (results)$2.56
Nov 6, 20258-K Item 2.02 (results)$6.00
Aug 7, 20258-K Item 2.02 (results)$9.69
May 8, 20258-K Item 2.02 (results)$10.78
Feb 20, 20258-K Item 2.02 (results)$10.71
Nov 7, 20248-K Item 2.02 (results)$24.57
Aug 8, 20248-K Item 2.02 (results)β€”
May 9, 20248-K Item 2.02 (results)β€”
Feb 22, 20248-K Item 2.02 (results)β€”
Jan 8, 20248-K Item 2.02 (results)β€”

Related stocks Β· Services-Management Services

Gartner (IT)Rentokil Initial (RTO)Dreamland (TDIC)Franklin Covey (FC)

Popular today

Micron Technology (MU)Spdr S&P 500 Etf (SPY)Nvidia (NVDA)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Intel (INTC)Apple (AAPL)Microsoft (MSFT)Meta Platforms (META)Broadcom (AVGO)Tesla (TSLA)

More on EVH

Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 15, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.